# An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts

> **NCT00000709** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (—)

## Conditions studied

- AIDS Dementia Complex
- HIV Infections

## Interventions

- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00000709
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1990-02
- **Target enrollment:** 50 (—)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000709, "An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*